Back to mobile site

H.C. Wainwright Assumes Citius Pharmaceuticals (CTXR) at Buy

May 18, 2026 8:57 AM EDT Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth assumes coverage on Citius Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login